# ACER1

## Overview
ACER1, or alkaline ceramidase 1, is a gene that encodes a transmembrane enzyme involved in the hydrolysis of ceramides into sphingosine and free fatty acids, playing a pivotal role in sphingolipid metabolism. This enzyme is primarily localized in the endoplasmic reticulum and is highly expressed in differentiated keratinocytes and sebaceous glands, particularly in the skin. The activity of alkaline ceramidase 1 is crucial for regulating cell differentiation, proliferation, and apoptosis, with significant implications for skin integrity and homeostasis. Dysregulation of ACER1 expression has been associated with various skin disorders, such as psoriasis, and gastrointestinal conditions like inflammatory bowel disease, highlighting its clinical significance in maintaining cellular and tissue health (Parveen2019Role; Sun2008Upregulation; Xu2021Alkaline).

## Function
ACER1 (alkaline ceramidase 1) is an enzyme that plays a critical role in sphingolipid metabolism by hydrolyzing ceramides into sphingosine and free fatty acids. This process is essential for maintaining the balance of ceramides and sphingolipids within cells, particularly in the skin. ACER1 is primarily localized in the endoplasmic reticulum and is highly expressed in differentiated keratinocytes, sebaceous glands, and the infundibulum of the skin (Parveen2019Role; Xu2021Alkaline).

The enzyme is involved in the regulation of cell differentiation, proliferation, and apoptosis. It is particularly important in the differentiation of epidermal keratinocytes, where its activity is influenced by calcium levels. Upregulation of ACER1 through calcium influx can induce growth arrest and differentiation of these cells, which is crucial for the formation and maintenance of the skin barrier (Sun2008Upregulation; Xu2021Alkaline).

In ACER1-deficient mice, increased ceramide levels lead to skin abnormalities, such as increased transepidermal water loss, abnormal hair shafts, and cyclic alopecia, highlighting its role in maintaining skin integrity and homeostasis (LiakathAli2016Alkaline). The enzyme's activity also affects whole-body energy expenditure, as its deficiency results in hypermetabolism and reduced fat content with age (LiakathAli2016Alkaline).

## Clinical Significance
Alterations in the expression of the ACER1 gene have been implicated in several diseases, particularly those affecting the skin and gastrointestinal tract. In the context of skin health, ACER1 is highly expressed in keratinocytes and plays a crucial role in their differentiation. Dysregulation of ACER1 expression can lead to skin disorders such as psoriasis, as it is located in a psoriasis susceptibility locus. The enzyme's role in generating sphingosine and sphingosine-1-phosphate is critical for keratinocyte growth arrest and differentiation, processes that are disrupted in psoriasis (Sun2008Upregulation).

In the gastrointestinal tract, ACER1 has been linked to inflammatory bowel disease (IBD). Studies have shown that ACER1 is upregulated in the intestines of mice with a deficiency in the manganese transporter gene Slc39a8, which exacerbates colitis symptoms. This upregulation is associated with altered ceramide metabolism, contributing to intestinal inflammation. Inhibiting ACER1 has been suggested as a potential therapeutic strategy for IBD, as it can improve gut barrier integrity and reduce inflammation in models of colitis (Choi2024The).


## References


[1. (Sun2008Upregulation) Wei Sun, Ruijuan Xu, Wei Hu, Junfei Jin, Heather A. Crellin, Jacek Bielawski, Zdzislaw M. Szulc, Bruce H. Thiers, Lina M. Obeid, and Cungui Mao. Upregulation of the human alkaline ceramidase 1 and acid ceramidase mediates calcium-induced differentiation of epidermal keratinocytes. Journal of Investigative Dermatology, 128(2):389–397, February 2008. URL: http://dx.doi.org/10.1038/sj.jid.5701025, doi:10.1038/sj.jid.5701025. This article has 70 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/sj.jid.5701025)

[2. (Choi2024The) Eun-Kyung Choi, Thekkelnaycke M. Rajendiran, Tanu Soni, Jin-Ho Park, Luisa Aring, Chithra K. Muraleedharan, Vicky Garcia-Hernandez, Nobuhiko Kamada, Linda C. Samuelson, Asma Nusrat, Shigeki Iwase, and Young Ah Seo. The manganese transporter slc39a8 links alkaline ceramidase 1 to inflammatory bowel disease. Nature Communications, June 2024. URL: http://dx.doi.org/10.1038/s41467-024-49049-8, doi:10.1038/s41467-024-49049-8. This article has 2 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-024-49049-8)

[3. (Xu2021Alkaline) Ruijuan Xu, Paul Antwi Boasiako, and Cungui Mao. Alkaline ceramidase family: the first two decades. Cellular Signalling, 78:109860, February 2021. URL: http://dx.doi.org/10.1016/j.cellsig.2020.109860, doi:10.1016/j.cellsig.2020.109860. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.cellsig.2020.109860)

[4. (Parveen2019Role) Farzana Parveen, Daniel Bender, Shi-Hui Law, Vineet Kumar Mishra, Chih-Chieh Chen, and Liang-Yin Ke. Role of ceramidases in sphingolipid metabolism and human diseases. Cells, 8(12):1573, December 2019. URL: http://dx.doi.org/10.3390/cells8121573, doi:10.3390/cells8121573. This article has 90 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells8121573)

[5. (LiakathAli2016Alkaline) Kifayathullah Liakath-Ali, Valerie E Vancollie, Christopher J Lelliott, Anneliese O Speak, David Lafont, Hayley J Protheroe, Camilla Ingvorsen, Antonella Galli, Angela Green, Diane Gleeson, Ed Ryder, Leanne Glover, Gema Vizcay-Barrena, Natasha A Karp, Mark J Arends, Thomas Brenn, Sarah Spiegel, David J Adams, Fiona M Watt, and Louise van der Weyden. Alkaline ceramidase 1 is essential for mammalian skin homeostasis and regulating whole-body energy expenditure: essential roles for alkaline ceramidase 1 in the skin. The Journal of Pathology, 239(3):374–383, May 2016. URL: http://dx.doi.org/10.1002/path.4737, doi:10.1002/path.4737. This article has 32 citations.](https://doi.org/10.1002/path.4737)